跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
BUPIVACAINE HYDROCHLORIDE INJECTION, USP
Authorized
STANDARD
BUPIVACAINE HYDROCHLORIDE INJECTION, USP
baxter corporation
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
9bac2bfc79a166b1
Company
baxter corporation
Type
Standard
Approval Details
Approval Id
9bac2bfc79a166b1
Drug Approval Canada Name
BUPIVACAINE HYDROCHLORIDE INJECTION, USP
Product Name
BUPIVACAINE HYDROCHLORIDE INJECTION, USP
Status
Marketed
Status Date
2022-08-15
Original Market Date
2022-08-15
Din
02488930
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Epidural , Retrobulbar
Schedule
Ethical
Ahfs
72:00.00
Atc Original
N01BB01 BUPIVACAINE
Atc Name
n 01 bb 01
Aig Number
0108896002
Company Name
baxter corporation
Company Address
7125 Mississauga Road, Mississauga, Ontario, Canada, L5N 0C2
Active Ingredients
BUPIVACAINE HYDROCHLORIDE
7.5 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
9bac2bfc79a166b1
Type
Standard
Back to Health Canada Approvals
BUPIVACAINE HYDROCHLORIDE INJECTION, USP - Health Canada Drug Approval Details